spacer
home > ebr > winter 2003 > future of electronic data capture in clinical trials
PUBLICATIONS
European Biopharmaceutical Review

Future of Electronic Data Capture in Clinical Trials

Clinical trials currently account for approximately 70 per cent of the US$403 million cost involved in bringing a new drug to market. This makes them an obvious target for those wanting to reduce drug discovery and development costs. The following scenario takes place in the future and suggests how technology may change the process.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Tony Dean, Director of Sales and Marketing at Datatrial Ltd

Tony Dean is Director of Sales and Marketing at Datatrial, a biometrics CRO. Tony graduated in Applied Biology and began working in the pharmaceutical industry in 1979 with SK&F, working at the bench in drug metabolism and pharmacokinetics. He subsequently moved into the CRO sector and held various positions within clinical project management prior to moving into business development five years ago.

spacer
Tony Dean
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Vaisala Introduces CAB100 Industrial Cabinet for Cleanrooms

Vaisala, a global leader in weather, environmental, and industrial measurements, launches its newest offering for centralized environmental monitoring in cleanrooms: The CAB100 integrates Vaisala’s world-class instruments for monitoring parameters into a simple, pre-configured enclosure.
More info >>

White Papers

Is Your Biobank Ready for the Challenge of Biomarker-based Research?

BioFortis

Targeted and personalized studies with well-defined patient segmentation biomarkers are becoming the norm in clinical trials. This increased interest in molecular biomarker studies necessitates a rigor and sophistication in sample management within the clinical trial context that is often not supported either by traditional clinical trial management software (CTMS), or biobanking systems.  Download our Next Generation Biobanking whitepaper and learn about how to overcome the key challenges in clinical trial sample management from working in a distributed network of partners and stakeholder to managing consents and generating scientific insights.
More info >>

 
Industry Events

CPhI & P-MEC China

18-20 June 2019, SNIEC, Shanghai, China

CPhI & P-MEC China 2019 is your gateway to successfully grow your business at the 2nd largest pharma market in the world. Whether you are looking for sourcing new business or getting the latest market insight, this is your one-stop shop pharmaceutical platform in Asia.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement